Eculizumab

Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival

(2011) R. J. Kelly et al.   BLOOD

Cardiopulmonary bypass in a patient with classic paroxysmal nocturnal hemoglobinuria during treatment with eculizumab

(2011) Sandra T. A. van Bijnen et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Chronic treatment of paroxysmal nocturnal hemoglobinuria patients with eculizumab: safety, efficacy, and unexpected laboratory phenomena

(2011) Alexander Röth et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Safety and efficacy of the terminal complement inhibitor eculizumab in Japanese patients with paroxysmal nocturnal hemoglobinuria: the AEGIS Clinical Trial

(2011) Yuzuru Kanakura et al.   INTERNATIONAL JOURNAL OF HEMATOLOGY

Achievements and Limitations of Complement Inhibition by Eculizumab in Paroxysmal Nocturnal Hemoglobinuria: The Role of Complement Component 3

(2011) A. M. Risitano et al.   MINI-REVIEWS IN MEDICINAL CHEMISTRY

Insufficient protection by Neisseria meningitidis vaccination alone during eculizumab therapy

(2011) Antonia Bouts et al.   PEDIATRIC NEPHROLOGY

A cascade of thromboembolic processes in a patient with paroxysmal nocturnal haemoglobinuria terminated by treatment with eculizumab

(2011) Roger E. G. Schutgens et al.   THROMBOSIS AND HAEMOSTASIS

Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria

(2010) Peter Hillmen et al.   AMERICAN JOURNAL OF HEMATOLOGY

The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab

(2010) Richard Kelly et al.   BRITISH JOURNAL OF HAEMATOLOGY

Effect of eculizumab on haemolysis-associated nitric oxide depletion, dyspnoea, and measures of pulmonary hypertension in patients with paroxysmal nocturnal haemoglobinuria

(2010) Anita Hill et al.   BRITISH JOURNAL OF HAEMATOLOGY

Highly active antiretroviral therapy alone may be an effective treatment for HIV-associated multi-centric Castleman's disease

(2010) S. M. Lee et al.   HAEMATOLOGICA

Paroxysmal nocturnal hemoglobinuria and eculizumab

(2010) L. Luzzatto et al.   HAEMATOLOGICA

Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization

(2010) A. Hill et al.   HAEMATOLOGICA

Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab

(2010) D. Helley et al.   HAEMATOLOGICA

The pathophysiology of paroxysmal nocturnal hemoglobinuria and treatment with eculizumab

(2010) Richard Kelly   Therapeutics and Clinical Risk Management

Successful discontinuation of anticoagulation following eculizumab administration in paroxysmal nocturnal hemoglobinuria

(2009) Ashkan Emadi et al.   AMERICAN JOURNAL OF HEMATOLOGY

How I treat paroxysmal nocturnal hemoglobinuria

(2009) R. A. Brodsky   BLOOD

Eculizumab for paroxysmal nocturnal haemoglobinuria

(2009) Charles Parker   LANCET

Global epidemiology of meningococcal disease

(2009) Lee H. Harrison et al.   VACCINE

Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria

(2008) Jrg Schubert et al.   BRITISH JOURNAL OF HAEMATOLOGY

Paroxysmal nocturnal hemoglobinuria (PNH) and pregnancy in the era of eculizumab

(2008) Alexey V. Danilov et al.   LEUKEMIA RESEARCH

Warfarin-induced bleeding complications — clinical presentation and therapeutic options

(2008) Christian J. Wiedermann et al.   THROMBOSIS RESEARCH